September 5, 2025Current OncologyOpen Access

Advances in Systemic Therapy for Hepatocellular Carcinoma and Future Prospects

View Full Paper

Ask AI

Bookmark

Transitioning from local to systemic drug therapies has significantly improved patient prognoses in hepatocellular carcinoma.
The combination of immunotherapy with atezolizumab and bevacizumab has led to superior outcomes compared to traditional therapies.
Integration of drug therapy with local methods like transarterial chemoembolization has further enhanced treatment effectiveness.
Emerging regimens and clinical trials are paving the way for more versatile treatment options for unresectable hepatocellular carcinoma cases.

Discussion

No takes yet. Share an insight, caveat, or question.

Review highlights systemic drug therapy efficacy in hepatocellular carcinoma, suggesting promising treatment combinations.

Sugimoto et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark